Beneficial effects of MET-88, a -butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction

Author: Hayashi Y.   Kirimoto T.   Asaka N.   Nakano M.   Tajima K.   Miyake H.   Matsuura N.  

Publisher: Elsevier

ISSN: 0014-2999

Source: European Journal of Pharmacology, Vol.395, Iss.3, 2000-05, pp. : 217-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract